FDA Approves First Year-Long Continuous Glucose Monitoring Sensor for Diabetes
Discover the impact of this breaking FDA approval of the first year-long Continuous Glucose Monitoring sensor—READ NOW!
The New Era of Continuous Glucose Monitoring (CGM) Expanding Access and Improving Outcomes
Explore advancements in OTC CGM systems. Plus, uncover the broader implications of these cutting-edge devices!
Continuous Glucose Monitor (CGM): Essential Insights for Pregnancy and Across the LifespanÂ
Discover the benefits of continuous glucose monitoring (CGM) during pregnancy and across the lifespan, and why HbA1C and blood figure sticks are outdated!
How To Overcome Clinical Disparities in Women with Chronic Kidney Disease (CKD)
Cardiovascular Mortality Risk Triples in T2D Patients with CKD Patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) face heightened risks of cardiovascular and renal morbidity and mortality. Diabetic kidney disease (DKD) is the leading cause of dialysis-dependent chronic kidney disease and end-stage renal disease (ESRD) in the US and most countries.  According to the […]
5 Keys to Patient Education on GLP-1 RAs for Weight Loss
As ‘magic’ weight loss drugs capture public attention, you’ve likely seen an uptick in patients asking about GLP-1 RAs for weight loss. As your go-to partner for cardiometabolic risk reduction research, industry news, and practical strategies, we’ve created this highly practical guide to help you educate patients on safe access to GLP-1 RAs for weight […]
Comprehensive Overview of GLP-1 RAs in Cardiometabolic Care
The not-so-sudden rise of weight loss ”wonder” drugs for T2D and obesity This World Obesity Day, March 4, 2024, weight loss drugs dominate discussions and raise new questions for clinicians. Glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) have been used to treat type 2 diabetes (T2D) since the approval of Byetta (exenatide) in 2005. In the […]
How to Get Free or Lower Cost Insulin for Your Medicare and Non-Medicare Patients: Shattering Barriers to Insulin Access
Astronomically high insulin costs have led to complications and barriers to access for millions of Americans with diabetes. After years of pressure from the government and activist groups, we are just beginning to see a trend toward lower, more affordable drug prices, with insulin at the forefront of the conversation. However, the complexities of state-regulated […]
The High Cost of Insulin: Bridging Gaps on the Path to Affordable Care
Why are insulin prices so high? Short history from development to today’s price hikes Doctors Frederick Banting and Charles Best successfully isolated the hormone insulin just over 100 years ago, dramatically changing the lives of those with diabetes. When Nobel Prize Winner Banting discovered insulin, out of ethical consideration, he refused to put his name […]
Kidney Week 2023: Top Ten Takeaways
More than 12,000 attendees flocked to Philadelphia, Pennsylvania, on Nov. 2-5, 2023, to gain perspective on the latest advances in the management of glomerular disease. Kidney Week 2023 not only served as a platform for the latest news and updates in the field but also marked the final meeting of the year for practitioners in […]
Cardiometabolic Health Congress (CMHC) Launches Focused Digital Education Hubs
Cardiometabolic health education leader CMHC announced that its digital education has been streamlined into 12 hubs organized by therapeutic or clinical topics for focused learning The digital education from worldwide cardiometabolic event leader CMHC has undergone a reorganization. A vast collection of webinars, CME activities, expert interviews, on-demand event recordings, news articles, drug pipelines, and […]
